The Skeletal Dysplasia Account Manager is a high-impact, community-focused role central to BridgeBio’s commercial success. This individual will drive the launch of Infigratinib—a first-in-class therapy for achondroplasia—bring deep clinical acumen, urgency, and a passion for partnering with providers and families. The role requires developing and executing a dynamic territory business plan, demonstrating deep expertise in Infigratinib and the skeletal dysplasia landscape, and building relationships with Key Opinion Leaders (KOLs). The position emphasizes a competitive mindset, business acumen, resilience, customer focus, clinical acumen, and strong account management skills. The ideal candidate will have a proven track record in pharmaceutical or biotech sales, specifically in rare diseases, and experience with product launches. They will operate with an “One Bridge” mindset, collaborating across the organization and maintaining integrity in all activities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior